# EDGAR Filing Document

**Accession Number:** 0001421642
**File Stem:** 0001104659-26-010959
**Filing Date:** 2026-2
**Character Count:** 6541
**Document Hash:** 8143b584d1a0e611c7d2420404eddf4a
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001104659-26-010959.hdr.sgml**: 20260205

**ACCESSION NUMBER**: 0001104659-26-010959

**CONFORMED SUBMISSION TYPE**: F-X

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20260205

**EFFECTIVENESS DATE**: 20260205

**SUBJECT COMPANY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Satellos Bioscience Inc.
- **CENTRAL INDEX KEY:** 0001421642

**ORGANIZATION NAME:**
- **EIN:** 000000000
- **STATE OF INCORPORATION:** Z4

**FILING VALUES:**
- **FORM TYPE:** F-X
- **SEC ACT:** 1933 Act
- **SEC FILE NUMBER:** 333-293229
- **FILM NUMBER:** 26603543

**BUSINESS ADDRESS:**
- **STREET 1:** ROYAL BANK PLAZA, S. TOWER, 200 BAY ST.
- **STREET 2:** SUITE 2800
- **CITY:** TORONTO
- **STATE:** A6
- **ZIP:** M5J 2J1
- **BUSINESS PHONE:** 416-708-0522

**MAIL ADDRESS:**
- **STREET 1:** ROYAL BANK PLAZA, S. TOWER, 200 BAY ST.
- **STREET 2:** SUITE 2800
- **CITY:** TORONTO
- **STATE:** A6
- **ZIP:** M5J 2J1

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** ICO THERAPEUTICS INC
- **DATE OF NAME CHANGE:** 20071218
**FILED BY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Satellos Bioscience Inc.
- **CENTRAL INDEX KEY:** 0001421642

**ORGANIZATION NAME:**
- **EIN:** 000000000
- **STATE OF INCORPORATION:** Z4

**FILING VALUES:**
- **FORM TYPE:** F-X

**BUSINESS ADDRESS:**
- **STREET 1:** ROYAL BANK PLAZA, S. TOWER, 200 BAY ST.
- **STREET 2:** SUITE 2800
- **CITY:** TORONTO
- **STATE:** A6
- **ZIP:** M5J 2J1
- **BUSINESS PHONE:** 416-708-0522

**MAIL ADDRESS:**
- **STREET 1:** ROYAL BANK PLAZA, S. TOWER, 200 BAY ST.
- **STREET 2:** SUITE 2800
- **CITY:** TORONTO
- **STATE:** A6
- **ZIP:** M5J 2J1

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** ICO THERAPEUTICS INC
- **DATE OF NAME CHANGE:** 20071218

**UNITED STATES SECURITIES AND EXCHANGE COMMISSION**

**WASHINGTON, D.C. 20549**

**FORM F-X**

**APPOINTMENT OF AGENT FOR SERVICE OF PROCESS<br> AND UNDERTAKING**

A. Name of issuer or person filing ("Filer"):

**SATELLOS BIOSCIENCE INC.**

B. (1) This is an (*check one*):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;⌧ original
 filing for the Filer.

◻ amended filing for the Filer.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2) Check
 the following box if you are filing the Form F-X in paper in accordance with Regulation S-T
 Rule 101(b)(9): ◻

C. Identify the filing in conjunction with which this
 Form is being filed:

---

| | |
|:---|:---|
| **Name of registrant:** | **SATELLOS BIOSCIENCE INC.** |

---

---

| | |
|:---|:---|
| **Form type:** | **Registration Statement on Form F-10** |

---

---

| | |
|:---|:---|
| **File Number (*if known*):** | **333-293229** |

---

---

| | |
|:---|:---|
| **Filed by:** | **SATELLOS BIOSCIENCE INC.** |

---

---

| | |
|:---|:---|
| **Date Filed (*if filed concurrently, so indicate*):** | **February 5, 2026 (filed concurrently)** |

---

D. The Filer is incorporated or organized under the laws
 of:

**Canada**

and has its principal place of business at:

**200 Bay Street, Suite 2800, Toronto, Ontario M5J 2J1, Canada**

**(647) 660-1780**

E. The Filer designates and appoints Satellos Bioscience US, Inc ("Agent")
 located at:

**Satellos Bioscience US, Inc.<br> 6 Liberty Square 2089**

**Boston, MA 02109**

**(647) 660-1780**

as the agent of the Filer upon whom may be served any process, pleadings, subpoenas, or other papers in:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) any investigation or administrative proceeding conducted by the Commission; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) any civil suit or action brought against the Filer or to which the Filer has been joined as defendant or respondent, in any appropriate court in any place subject to the jurisdiction of any state or of the United States or of any of its territories or possessions or of the District of Columbia, where the investigation, proceeding or cause of action arises out of or relates to or concerns any offering made or purported to be made in connection with the securities registered or qualified by the Filer on Form F-10 on the date hereof, or any purchases or sales of any security in connection therewith. The Filer stipulates and agrees that any such civil suit or action or administrative proceeding may be commenced by the service of process upon, and that service of an administrative subpoena shall be effected by service upon such agent for service of process, and that service as aforesaid shall be taken and held in all courts and administrative tribunals to be valid and binding as if personal service thereof had been made.

F. The Filer, in connection with the use of Form F-10, stipulates and agrees to appoint a successor agent for service of process and file an amended Form F-X if the Filer discharges the Agent or the Agent is unwilling or unable to accept service on behalf of the Filer at any time until six years have elapsed from the date the issuer of the securities to which such Forms and Schedules relate has ceased reporting under the Exchange Act. The Filer further undertakes to advise the Commission promptly of any change to the Agent's name or address during such period by amendment of this Form, referencing the file number of the Form F-10 in conjunction with which the amendment is being filed.

G. The Filer undertakes to make available, in person or by telephone, representatives to respond to inquiries made by the Commission staff, and to furnish promptly, when requested to do so by the Commission staff, information relating to the Form F-10, the securities to which the Form F-10 relates; and the transactions in such securities.

The Filer certifies that it has duly caused this power of attorney, consent, stipulation and agreement to be signed on its behalf by the undersigned, thereunto duly authorized, in Toronto, Ontario, Canada, on February 5, 2026.

---

| | | |
|:---|:---|:---|
| Filer: | **SATELLOS BIOSCIENCE INC.** | **SATELLOS BIOSCIENCE INC.** |
|  | By: | /s/ Elizabeth Williams, CPA, CA |
|  |  | Name: Elizabeth Williams, CPA, CA |
|  |  | Title: Chief Financial Officer |

---

This statement has been signed by the following person in the capacity and on the date indicated.

---

| | |
|:---|:---|
| **SATELLOS BIOSCIENCE US, INC.** | **SATELLOS BIOSCIENCE US, INC.** |
| (Agent for Service) | (Agent for Service) |
| By: | /s/ Frank Gleeson, MBA |
|  | Name: Frank Gleeson, MBA |
|  | Title: President and Chief Executive Officer |
|  | Date: February 5, 2026 |

---